Javascript must be enabled to continue!
Murine Mammary Tumour Cells In Vitro. I. the Development of A Quiescent State
View through CrossRef
Abstract Three mouse mammary tumour lines (66, 67, and 68H) derived from a single mouse mammary tumour were investigated for their growth kinetics and development of quiescent cells in unfed monolayer cultures. All three lines develop pure quiescent populations when grown in unfed plateau cultures. A dramatic cell‐cycle redistribution accompanied the proliferating (P) to quiescent (Q) transition, with the percentage of cells having a G1 DNA content increasing from 50% in the P state to <97% in the Q state. As the cultures progressed from exponential to plateau growth, a decrease of 50% in cellular RNA was observed in all three lines. This property enables the clear identification of P v. Q cells by flow cytometry using the two‐step acridine orange assay. Autoradiographic data verified that these plateau cells were quiescent since >2.5% of the cells incorporated [3H]TdR when labelled for approximately two doubling times. Further comparison of the P and Q cells showed that: (a) the Coulter volume of Q cells was approximately half that of P cells in all three lines; (b) viability, as measured by dye exclusion was >95% in all cultures regardless of their proliferative state; and (c) colony‐forming ability decreased as the cells entered the quiescent state. In each of these cell lines the development of Q‐cell populations was marked by similar changes in all measured parameters. These quiescent tumour cells provide a relatively simple model to evaluate what, if any, important differences exist between the response of P v. Q cells to various therapeutic agents.
Title: Murine Mammary Tumour Cells In Vitro. I. the Development of A Quiescent State
Description:
Abstract Three mouse mammary tumour lines (66, 67, and 68H) derived from a single mouse mammary tumour were investigated for their growth kinetics and development of quiescent cells in unfed monolayer cultures.
All three lines develop pure quiescent populations when grown in unfed plateau cultures.
A dramatic cell‐cycle redistribution accompanied the proliferating (P) to quiescent (Q) transition, with the percentage of cells having a G1 DNA content increasing from 50% in the P state to <97% in the Q state.
As the cultures progressed from exponential to plateau growth, a decrease of 50% in cellular RNA was observed in all three lines.
This property enables the clear identification of P v.
Q cells by flow cytometry using the two‐step acridine orange assay.
Autoradiographic data verified that these plateau cells were quiescent since >2.
5% of the cells incorporated [3H]TdR when labelled for approximately two doubling times.
Further comparison of the P and Q cells showed that: (a) the Coulter volume of Q cells was approximately half that of P cells in all three lines; (b) viability, as measured by dye exclusion was >95% in all cultures regardless of their proliferative state; and (c) colony‐forming ability decreased as the cells entered the quiescent state.
In each of these cell lines the development of Q‐cell populations was marked by similar changes in all measured parameters.
These quiescent tumour cells provide a relatively simple model to evaluate what, if any, important differences exist between the response of P v.
Q cells to various therapeutic agents.
Related Results
Abstract A05: Deep immunofluorescence imaging of solvent-cleared mouse mammary glands
Abstract A05: Deep immunofluorescence imaging of solvent-cleared mouse mammary glands
Abstract
We seek to trace the progression of epithelial lesions originating from Lgr5+ cells in mouse mammary glands using the 3DISCO protocol for solvent-cleared ti...
TRIB1 regulates tumour growth via controlling tumour-associated macrophage phenotypes and is associated with breast cancer survival and treatment response
TRIB1 regulates tumour growth via controlling tumour-associated macrophage phenotypes and is associated with breast cancer survival and treatment response
SummaryMolecular mechanisms that regulate tumour-associated macrophage (TAM) phenotype and function are incompletely understood. Here, we show that the pseudokinase TRIB1 is highly...
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
AbstractBackgroundMammary tumours frequently develop in female domestic cats being highly malignant in a large percentage of cases. Chemokines regulate many physiological and patho...
Tumour Immunology
Tumour Immunology
Abstract
Tumour immunology is central to our understanding of the mechanisms of both tumour rejection and tumour progression. Vir...
Regulation of adipocyte lipid homeostasis by genistein alters mammary epithelial cell differentiation: a paracrine mechanism for mammary tumor protection.
Regulation of adipocyte lipid homeostasis by genistein alters mammary epithelial cell differentiation: a paracrine mechanism for mammary tumor protection.
Abstract
Abstract #5082
Epidemiological and animal studies have shown a negative correlation between breast cancer incidence and intake of soy-rich fo...
Murine Mammary Tumour Cells In Vitro. Ii. Recruitment of Quiescent Cells
Murine Mammary Tumour Cells In Vitro. Ii. Recruitment of Quiescent Cells
Abstract The development of a pure quiescent (Q) tumour cell population can be induced in three mouse mammary tumour lines (66, 67 and 68H) by nutrient deprivation. When these Q ce...
A pleiotropic role for FGF signaling in mammary gland stromal fibroblasts
A pleiotropic role for FGF signaling in mammary gland stromal fibroblasts
AbstractFibroblast growth factor (FGF) signaling is crucial for mammary gland development. While multiple roles for FGF signaling in the epithelium were described, the function of ...
Abstract 283: Osteopontin cleavage fragments drive FGFR1-mediated mammary tumorigenesis
Abstract 283: Osteopontin cleavage fragments drive FGFR1-mediated mammary tumorigenesis
Abstract
Breast cancer is the second leading cause of cancer-related deaths in women in the United States. Over 40,000 women in the U.S. die of breast cancer annuall...

